$15.62
Price
$1.1B
Market Cap
—
P/E Ratio
-4.2
Forward P/E
$-3.33
EPS (TTM)
—
Dividend Yield
$380M
Cash
$3M
Total Debt
71M
Shares Out
$5.95
$62.75
52-Week Range
Institutional Ownership of Moonlake Immunotherapeutics
|
Fund / Manager
Click to search
|
Shares | Value | % of Portfolio | Cost Basis | Est. Return |
|---|---|---|---|---|---|
| No funds currently hold this stock. | |||||
Trading Activity for Moonlake Immunotherapeutics
|
Fund / Manager
Click to search
|
Action | Change | Shares After | Value | Price |
|---|---|---|---|---|---|
| No activity found for this stock. | |||||
Insider Trading for Moonlake Immunotherapeutics
No Insider Transactions
No Form 4 filings found for this stock in the last 2 years.